Cognex Corporation $CGNX Shares Acquired by Vanguard Personalized Indexing Management LLC

Key Points

• Vanguard Personalized Indexing Management LLC boosted its holdings in Cognex Corporation by 120.7% during the 2nd quarter, acquiring an additional 20,357 shares to bring their total to 37,224 shares valued at $1.18 million.
• Several analysts have raised their price targets for Cognex, with Needham & Company increasing its target from $36 to $45, reflecting a bullish outlook on the company.
• Cognex recently declared a quarterly dividend of $0.08 per share, which reflects an annualized dividend of $0.32 and a yield of 0.7%.

Vanguard Personalized Indexing Management LLC increased its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 120.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,224 shares of the scientific and technical instruments company's stock after purchasing an additional 20,357 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in Cognex were worth $1,181,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Mackenzie Financial Corp lifted its position in shares of Cognex by 126.2% in the 1st quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after buying an additional 2,571,457 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its position in shares of Cognex by 32.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock valued at $181,436,000 after buying an additional 1,474,832 shares during the last quarter. ING Groep NV acquired a new stake in Cognex during the first quarter worth about $22,191,000. Price T Rowe Associates Inc. MD lifted its holdings in Cognex by 34.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock worth $75,756,000 after acquiring an additional 647,955 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in Cognex in the second quarter worth about $17,268,000. Institutional investors own 88.12% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently commented on CGNX. Needham & Company LLC upped their target price on Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Citigroup restated a "neutral" rating and set a $37.00 price objective (up previously from $30.00) on shares of Cognex in a research report on Monday, July 14th. KeyCorp upgraded Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price objective for the company in a research note on Friday, August 1st. Barclays set a $55.00 target price on Cognex and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Finally, UBS Group boosted their price target on shares of Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a report on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $44.93.

Insider Activity

In other news, EVP Sheila Marie Dipalma sold 2,002 shares of the business's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the sale, the executive vice president owned 8,582 shares of the company's stock, valued at approximately $386,190. The trade was a 18.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company's stock.

Cognex Stock Down 0.6%

Shares of CGNX opened at $46.04 on Friday. The firm has a market capitalization of $7.73 billion, a PE ratio of 64.85 and a beta of 1.50. The firm has a 50-day moving average price of $44.62 and a 200 day moving average price of $35.46. Cognex Corporation has a 52-week low of $22.67 and a 52-week high of $47.52.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. The company had revenue of $249.09 million during the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts expect that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were paid a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Thursday, August 14th. Cognex's dividend payout ratio (DPR) is presently 45.07%.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.